Bentley University Professor Dhaval Dave Examines How a Rise in Advertising Expenditures by Pharmaceutical Companies Affects Consumer Drug Prices
Changes in federal regulation in the late 1990s spurred spending on direct-to-consumer advertising (DTCA) of pharmaceutical drugs in the U.S. from $150 million in 1993 to $4.24 billion in 2005.